1Ian S. Zagon.Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancer[J].Open Access Journal of Clinical Trials (default).2010(default)
2Ian Zagon,Shawn Kreiner,Jeffery Heslop,Andrea Conway,Clinton Morgan,Patricia McLaughlin.Prevention and delay in progression of human pancreatic cancer by stableoverexpression of the opioid growth factor receptor[J].International Journal of Oncology.2008(2)
3Ian S. Zagon,Kristen A. Rahn,Patricia J. McLaughlin.Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells[J].Neuropeptides.2007(6)
4Ian S. Zagon,Jeffrey R. Jaglowski,Michael F. Verderame,Jill P. Smith,Alphonse E. Leure-duPree,Patricia J. McLaughlin.Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma[J].Cancer Chemotherapy and Pharmacology.2005(5)
5Ian S. Zagon,Patricia J. McLaughlin.Opioids and differentiation in human cancer cells[J].Neuropeptides.2005(5)
6Jill P. Smith,Robert L. Conter,Sandra I. Bingaman,Harold A. Harvey,David T. Mauger,Mejdi Ahmad,Lawrence M. Demers,Wayne B. Stanley,Patricia J. McLaughlin,Ian S. Zagon.Treatment of advanced pancreatic cancer with opioid growth factor: phase I[J].Anti-Cancer Drugs.2004(3)
7Ian S Zagon,Patricia J McLaughlin.Opioids and the apoptotic pathway in human cancer cells[J].Neuropeptides.2003(2)
8Ian S Zagon,Michael F Verderame,Patricia J McLaughlin.The biology of the opioid growth factor receptor (OGFr)[J].Brain Research Reviews.2002(3)
9GEOFFREY J. BISIGNANI,PATRICIA J. MCLAUGHLIN,SARAH D. ORDILLE,M. SCOTT BELTZ,MARK V. JAROWENKO,IAN S. ZAGON.HUMAN RENAL CELL CANCER PROLIFERATION IN TISSUE CULTURE IS TONICALLY INHIBITED BY OPIOID GROWTH FACTOR[J].The Journal of Urology.1999(6)
10YanWu,Patricia J.Mclaughlin,Ian S.Zagon.Ontogeny of the opioid growth factor, [Met<sup>5</sup>]‐enkephalin, preproenkephalin gene expression, and the ζ opioid receptor in the developing and adult aorta of rat[J].Dev Dyn.1998(4)
